Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Eurasian Journal of Research, Development and Innovation, [S. l.], v. 26, p. 1–4, 2023. Disponível em: https://geniusjournals.org/index.php/ejrdi/article/view/5178. Acesso em: 30 jan. 2026.